Western blot analysis demonstrated SL‐treated TRIM16‐knockdown GBM cells exhibited markedly reduced levels of OPTN, LC3B‐II/I, cleaved Caspase‐9, and cleaved Caspase‐3 (Figure 5E; Figure S14B, Supporting Information). The gene discussed is TRIM16; the disease is glioblastoma.